Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Frequency and Intensity of Local Reactions with 4% 5-FU vs 4% 5-FU plus Dexeryl in Actinic Keratosis
2020-000851-11Phase 4Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of fluorouracil in actinic keratosis (AK) (2 arms), sponsored by Pierre Fabre Laboratories. Primary endpoint: Local Skin Reaction (LSR) total score. Started Jul 2020; status: completed.
02
Drugs
fluorouracil
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2020-000851-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000851-11.